Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

TRIAL ALERTS

Site Listing

Please choose the site that is most convenient for you

Study Name: Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
3 locations found

University of Virginia Cancer Center
Location: Charlottesville, Virginia 22908
Holden Comprehensive Cancer Center at University of Iowa
Location: Iowa City, Iowa 52242
Mayo Clinic
Location: Rochester, Minnesota 55905

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.

TRIAL ALERTS

HEALTH NEWS

RSS FEEDS

ABOUT TRIALS

LINK TO US

Site Listing